Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766009 · ClinicalTrials.gov registry record · NA
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
A NA study of Breast Cancer Stage II and Breast Cancer Stage III, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- NA
- Development phase
- 627
- Enrollment target
- 20
- Study locations
NCT03766009: Active NA study of Breast Cancer Stage II and Breast Cancer Stage III, sponsored by Alliance for Clinical Trials in Oncology.
NCT03766009 is a NA study of Breast Cancer Stage II and Breast Cancer Stage III that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 627 participants, above the 153-participant average among 22 other Breast Cancer Stage II trials with a reported enrollment target (310% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03766009, a NA study of Breast Cancer Stage II and Breast Cancer Stage III, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 627 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more likely to be experienced by socioeconomically disadvantaged patients.
Primary Outcome
Power is defined as patients' self-perceived capacity to influence the decision-making encounter. This construct is measured using the Patient's Self-Efficacy in Patient-Physician Interactions (PEPPI)-5 point scale; the primary outcome measure is a total score ranging from 5-25, where higher scores indicate increased self-efficacy. The patient completes the PEPPI-5 questionnaire within 3 weeks post-surgical consultation.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Web-based decision aid
Study Locations (20)
Hawaii
- Hawaii Cancer Care Inc - Waterfront Plaza - Honolulu
- Island Urology - Honolulu
- Queen's Cancer Cenrer - POB I - Honolulu
- Queen's Medical Center - Honolulu
- Straub Clinic and Hospital - Honolulu
- University of Hawaii Cancer Center - Honolulu
- Hawaii Cancer Care Inc-Liliha - Honolulu
- Kuakini Medical Center - Honolulu
- Queen's Cancer Center - Kuakini - Honolulu
- The Cancer Center of Hawaii-Liliha - Honolulu
- Kapiolani Medical Center for Women and Children - Honolulu
- Wilcox Memorial Hospital and Kauai Medical Clinic - Lihue
California
- Epic Care-Dublin - Dublin
- Bay Area Breast Surgeons Inc - Emeryville
- Epic Care Partners in Cancer Care - Emeryville
- Contra Costa Regional Medical Center - Martinez
- Alta Bates Summit Medical Center - Summit Campus - Oakland
- Bay Area Tumor Institute - Oakland
- Epic Care Cyberknife Center - Walnut Creek
Georgia
- Augusta University Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 627 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What the registry record for NCT03766009 still lists
NCT03766009 is an interventional study that assigns participants to a tested intervention. The registered 627 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 22 other Breast Cancer Stage II trials with a reported enrollment target (310% higher).
The record links to 4 conditions, with Breast Cancer Stage II appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03766009 names 20 study sites across 3 states, led by Hawaii, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT03766009 about?
NCT03766009 is a clinical study titled "Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making". This trial studies how well a breast cancer surgery decision aid works in increasing patient engagement in decision making for patients with newly diagnosed stage 0-III breast cancer. The trial also examines barriers to patient engagement even with the use of a decision aid, and if barriers are more...
What is the current status of trial NCT03766009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 627 participants. The study started on 2019-06-05. Estimated completion is 2026-12-15.
What conditions does trial NCT03766009 study?
This clinical trial studies the following conditions: Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage I, Breast Cancer Stage 0.
What interventions are being tested in trial NCT03766009?
The interventions under investigation include: Usual Care (OTHER), Web-based decision aid (OTHER).
Who is sponsoring clinical trial NCT03766009?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03766009 being conducted?
This trial has 20 study locations across California, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Stage II
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03766009's enrollment target sits among peer trials
627 3rd of 22 higher than 20 of 22 other Breast Cancer Stage II trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Stage II trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
RECRUITING · NA
-
Optimizing Surgical Decisions in Young Adults With Breast Cancer
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
RECRUITING · NA
-
A Study of Language Interpretation Solutions for People With Breast Cancer
RECRUITING · NA
-
A Study of the TheraBionic P1 Device in Breast Cancer
RECRUITING · NA
-
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06040827 · 626 participants
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI